Susquehanna Portfolio Strategies’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.68M Sell
71,995
-56,965
-44% -$1.23M 0.02% 535
2025
Q4
$2.58M Buy
128,960
+84,740
+192% +$1.65M 0.04% 448
2025
Q3
$807K Sell
44,220
-28,835
-39% -$562K 0.01% 725
2025
Q2
$1.47M Buy
+73,055
New +$1.4M 0.03% 436
2024
Q2
Sell
-25,443
Closed -$388K 635
2024
Q1
$388K Hold
25,443
0.01% 628
2023
Q4
$408K Buy
+25,443
New +$356K 0.01% 803

Other funds holding INVA

Susquehanna Portfolio Strategies's INVA Position: Q1 2026 in Review

Susquehanna Portfolio Strategies reduced its Innoviva (INVA) stake by 44% in Q1 2026, selling an estimated $1.23M and leaving 71,995 shares worth $1.68M. The position accounts for 0.02% of the portfolio, ranked #535.

Susquehanna Portfolio Strategies first reported a position in INVA in Q4 2023 and has held it in 6 quarters since. The position peaked at $2.58M in Q4 2025. 286 funds tracked by Wall St. Rank hold INVA as of Q1 2026.

  • Susquehanna Portfolio Strategies held 71,995 shares of Innoviva worth $1.68M as of Q1 2026.
  • Susquehanna Portfolio Strategies sold 56,965 Innoviva shares in Q1 2026, an estimated $1.23M.
  • Innoviva made up 0.02% of Susquehanna Portfolio Strategies's portfolio in Q1 2026, its #535 holding.
  • Susquehanna Portfolio Strategies first reported a position in Innoviva in Q4 2023 and has held it in 6 quarters since.
  • Susquehanna Portfolio Strategies's Innoviva position peaked at $2.58M in Q4 2025.
  • 286 funds tracked by Wall St. Rank held Innoviva as of Q1 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q1 2026, filed 15 May 2026.